Article | November 10, 2022

10 Ways To Improve Your CDMO Partnerships

Source: Apprentice

By Joyce Lifland, PhD, Senior Sales Executive, Apprentice


In 2021, the pharmaceutical Contract Development and Manufacturing (CDMO) market size was valued at $186.62 billion, and is expected to grow to a whopping $289.64 by 2027 — representing a compound annual growth rate of 7.29%.

Although the market is poised for rapid growth, various challenges related to the pandemic (including a massive uptick in demand) have resulted in long CDMO lead times, supply shortages, and visibility issues. 

In this article, we’ll explore what CDMOs are, why they’re necessary, and ten ways pharma companies can improve their partnerships — regardless of market conditions.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online